Department of Cardiothoracic Surgery, School of Health Sciences, University of Thessaly, Larisa, Greece.
Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
J Card Surg. 2022 Oct;37(10):3365-3373. doi: 10.1111/jocs.16805. Epub 2022 Jul 28.
Το perform a systematic review with meta-analysis of published data comparing outcomes between a percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in dialysis-dependent patients.
We searched PubMed, Scopus, and Cochrane databases for studies including dialysis-dependent patients who underwent either CABG or PCI. This meta-analysis follows the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. We conducted one-stage and two-stage meta-analysis with Kaplan-Meier-derived individual patient data for overall survival and meta-analysis with the random-effects model for the in-hospital mortality and repeat revascularization.
Twelve studies met our eligibility criteria, including 13,651 and 28,493 patients were identified in the CABG and PCI arms, respectively. Patients who underwent CABG had overall improved survival compared with those who underwent PCI at the one-stage meta-analysis (hazard ratio [HR]: 1.12, 95% confidence interval [CI]: 1.09-1.16, p < .0001) and the two-stage meta-analysis (HR: 1.15, 95% CI: 1.08-1.23, p < .001, I = 30.0%). Landmark analysis suggested that PCI offers better survival before the 8.5 months of follow-up (HR: 0.96, 95% CI: 0.92-0.99, p = .043), while CABG offers an advantage after this timepoint (HR: 1.3, 95% CI: 1.22-1.32, p < .001). CABG was associated with increased odds for in-hospital mortality (odds ratio [OR]: 1.70, 95% CI: 1.50-1.92, p < .001, I = 0.0%) and decreased odds for repeat revascularization (OR: 0.22, 95% CI: 0.14-0.34, p < .001, I = 58.08%).
In dialysis-dependent patients, CABG was associated with long-term survival but a higher risk for early mortality. The risk for repeat revascularization was higher with PCI.
系统评价和荟萃分析比较了依赖透析患者经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)的结局。
我们在 PubMed、Scopus 和 Cochrane 数据库中检索了纳入接受 CABG 或 PCI 的依赖透析患者的研究。这项荟萃分析遵循系统评价和荟萃分析首选报告项目的建议。我们对整体生存进行了一阶和两阶荟萃分析,使用 Kaplan-Meier 衍生的个体患者数据;对住院死亡率和重复血运重建进行了随机效应模型荟萃分析。
12 项研究符合纳入标准,CABG 组和 PCI 组分别纳入了 13651 例和 28493 例患者。在一阶荟萃分析(风险比 [HR]:1.12,95%置信区间 [CI]:1.09-1.16,p < .0001)和二阶荟萃分析(HR:1.15,95% CI:1.08-1.23,p < .001,I = 30.0%)中,接受 CABG 的患者总体生存率优于接受 PCI 的患者。里程碑分析表明,在 8.5 个月的随访之前,PCI 提供了更好的生存率(HR:0.96,95% CI:0.92-0.99,p = .043),而在此时间点之后,CABG 提供了优势(HR:1.3,95% CI:1.22-1.32,p < .001)。CABG 与住院死亡率增加相关(比值比 [OR]:1.70,95% CI:1.50-1.92,p < .001,I = 0.0%),与重复血运重建减少相关(OR:0.22,95% CI:0.14-0.34,p < .001,I = 58.08%)。
在依赖透析的患者中,CABG 与长期生存相关,但早期死亡率较高。PCI 重复血运重建的风险较高。